Genetic Technologies Limited

GTG

AU000000GTG7

Healthcare Facilities & Services

Market Closed - Australian S.E. Other stock markets 11:40:53 31/05/2024 am IST			5-day change	1st Jan Change
0.1 ^AUD	-.--%		-9.09%	-25.93%

29/05	Accelerating Domestic Inflation Drags Australian Shares to More than Three-Week Low	MT
29/05	Genetic Technologies Releases Risk Assessment Test for Breast, Ovarian Cancer; Shares Jump 14%	MT

Genetic Technologies Limited Announces Board Appointments

November 28, 2019 at 08:32 am IST

Genetic Technologies Limited elected Nick Burrows and Peter Rubinstein as directors, at its AGM held on 28 November 2019.

Latest news about Genetic Technologies Limited

Accelerating Domestic Inflation Drags Australian Shares to More than Three-Week Low	29/05	MT
Genetic Technologies Releases Risk Assessment Test for Breast, Ovarian Cancer; Shares Jump 14%	29/05	MT
Genetic Technologies Limited Announces Execution of Strategic Joint Sales & Marketing Agreement with Wellworks for You Inc	06/05	CI
Genetic Technologies Signs Sales, Marketing Deal with Wellworks for You	06/05	MT
Genetic Technologies Raising $2 Million via ADS Offering	19/04	MT
Top Midday Decliners	19/04	MT
Genetic Technologies Agrees to $2 Million Equity Offering	18/04	MT
Genetic Technologies Limited Establishes Precision Oncology Division	17/04	CI
Genetic Technologies Launches GeneType Precision Oncology Brand, Diagnostic Tests	17/04	MT
Genetic Technologies Limited Establishes Clinical Implementation Study with Breast Screen Centres Across New York, Miami and Houston	11/04	CI
Genetic Technologies to Conduct Breast Cancer Integration Study in US	11/04	MT
Genetic Technologies Secures Short-Term Loan from Radium Capital	26/03	MT
Genetic Technologies Limited Announces the Appointment of Kathryn Andrews as Chief Financial Officer	25/03	CI
Genetic Technologies Limited Announces the Appointment of Kathryn Andrews as Company Secretary	25/03	CI
Genetic Technologies Limited to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare	25/03	CI
Genetic Technologies Appoints CFO	25/03	MT
Genetic Technologies Developing 'Most Advanced' Risk-Assessment Test for Serious Diseases; Shares Rise	22/03	MT
Genetic Technologies to Work on Advanced Comprehensive Risk Test; Shares Jump 18%	22/03	MT
Genetic Technologies to Launch US Advertising Campaign for Genome-Based Risk Assessment Test; Shares Surge 21%	28/02	MT
Genetic Technologies Limited Reports Earnings Results for the Half Year Ended December 31, 2023	23/02	CI
Genetic Technologies Limited Announces Resignation of Nick Burrows as an Independent Non-Executive Director	15/02	CI
Genetic Technologies Reports AU$3.6 Million in Q4 Cash Receipts	31/01	MT
Genetic Technologies' CFO and Company Secretary Resigns; Shares Rise 3%	08/01	MT
Genetic Technologies Limited Announces Resignation of Tony Di Pietro as Chief Financial Officer	08/01	CI
Genetic Technologies Limited Announces Resignation of Tony Di Pietro as Company Secretary	08/01	CI

Chart Genetic Technologies Limited

Duration

Period

More charts

Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its geneType and EasyDNA brands. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The Company operates through three segments: EasyDNA, AffinityDNA, and GeneType / Corporate. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses. GeneType / Corporate segment relates to geneType branded test sales and expenses, including corporate charges. The GeneType test is for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and mor

Sector

Healthcare Facilities & Services

Calendar

29/08/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
GENETIC TECHNOLOGIES LIMITED	-25.93%	8.78M
HCA HEALTHCARE, INC.	+25.52%	88.99B
CVS HEALTH CORPORATION	-24.52%	74.82B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-5.56%	25.03B
FRESENIUS SE & CO. KGAA	+4.31%	17.88B
LABCORP HOLDINGS INC.	-14.25%	16.43B
QUEST DIAGNOSTICS INCORPORATED	+2.97%	15.77B
TENET HEALTHCARE CORPORATION	+79.20%	13.21B
NATERA, INC.	+70.11%	13.09B
DAVITA INC.	+40.44%	12.9B